Literature DB >> 18306150

Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).

Sabine Ruths1, Jørund Straand, Harald A Nygaard, Dag Aarsland.   

Abstract

BACKGROUND: Despite modest efficacy, unpredictable individual utility, and a high rate of adverse effects, behavioural and psychological symptoms of dementia (BPSD) are common determinants for antipsychotic drug therapy in nursing home patients. AIMS: To explore the impact on BPSD of stopping long-term antipsychotic treatment in nursing home patients with dementia.
METHODS: Fifty-five patients (43 women; mean age 84.1) taking haloperidol, risperidone, or olanzapine for BPSD were randomly assigned to cessation (intervention group, n=27) or continued treatment with antipsychotic drugs (reference group, n=28) for 4 consecutive weeks. The Neuropsychiatric Inventory (NPI) Questionnaire was used to examine changes in behavioural and psychological symptoms.
RESULTS: By study completion, 23 of the 27 intervention group patients were still off antipsychotics. Symptom scores (NPI) remained stable or even improved in 42 patients (intervention group, 18 out of 27; reference group, 24 out of 28; p=0.18). As compared to patients with stable or improved symptom scores, patients with behavioural deterioration after antipsychotic cessation used higher daily drug doses at baseline (p=0.42).
CONCLUSION: A large share of elderly nursing home patients on long-term treatment with antipsychotics for BPSD, do well without this treatment. Standardized symptom evaluations and drug cessation attempts should therefore be undertaken at regular intervals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306150     DOI: 10.1002/gps.1998

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  26 in total

Review 1.  Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.

Authors:  Salvatore Gentile
Journal:  Psychopharmacology (Berl)       Date:  2010-07-27       Impact factor: 4.530

Review 2.  Interventions to improve suboptimal prescribing in nursing homes: A narrative review.

Authors:  Zachary A Marcum; Steven M Handler; Rollin Wright; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2010-06

Review 3.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

Review 4.  Medication safety in residential aged-care facilities: a perspective.

Authors:  Nicholas M Wilson; Lyn M March; Philip N Sambrook; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-10

Review 5. 

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

Review 6.  Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Authors:  Marta Miarons; Christopher Cabib; Francisco Javier Barón; Laia Rofes
Journal:  Eur J Clin Pharmacol       Date:  2017-08-05       Impact factor: 2.953

Review 7.  Psychosocial interventions for reducing antipsychotic medication in care home residents.

Authors:  Tanja Richter; Gabriele Meyer; Ralph Möhler; Sascha Köpke
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 8.  Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

Review 9.  Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia.

Authors:  Jennifer Tjia; Marcus M Reidenberg; Jacob N Hunnicutt; Kelli Paice; Jennifer L Donovan; Abir Kanaan; Becky A Briesacher; Kate L Lapane
Journal:  Consult Pharm       Date:  2015-10

10.  Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials.

Authors:  Sioe Lie Thio; Joana Nam; Mieke L van Driel; Thomas Dirven; Jeanet W Blom
Journal:  Br J Gen Pract       Date:  2018-10       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.